Blood product use among neonates at risk of transfusion*, 2001–2011
| Births N | Red cells N (row %) | Platelets N (row %) | Exchange N (row %) | Blood products N (row %) | No blood products N (row %) | |
|---|---|---|---|---|---|---|
| Total neonates | 989 491 | 4737 (0.5) | 1272 (0.1) | 264 (0.0) | 5326 (0.5) | 984 165 (99.5) |
| Neonates at risk of transfusion: | ||||||
| Severe fetal anaemia requiring In utero transfusion | 65 | 36 (55.4) | (8)† | 10 (15.4) | 41 (63.1) | 24 (36.9) |
| Fetal blood loss | 195 | 139 (71.3) | 25 (12.8) | (3)† | 140 (71.8) | 55 (28.2) |
| Birth trauma with haemorrhage | 184 | 15 (8.2) | 10 (5.4) | 18 (9.8) | 166 (90.2) | |
| Hereditary blood cell disorder | 130 | 38 (29.2) | 6 (4.6) | 7 (5.4) | 43 (33.1) | 87 (66.9) |
| Hereditary coagulation disorder | 45 | (11)† | (9)† | (2)† | 7 (15.6) | 38 (84.4) |
| Major congenital abnormality requiring surgery | 1670 | 697 (41.7) | 375 (22.5) | 735 (44.0) | 935 (56.0) | |
| Haemolytic disorders | 11 594 | 992 (8.6) | 230 (2.0) | 210 (1.8) | 1227 (10.6) | 10 367 (89.4) |
| Neonates transfused in the absence of conditions listed above: | ||||||
| Preterm ≤32 weeks weeks | 11 779 | 2361 (20.0) | 339 (2.9) | 8 (0.1) | 2452 (20.8) | 9327 (79.2) |
| 33–36 weeks—assisted ventilation | 1910 | 137 (7.2) | 43 (2.3) | (0)† | 154 (8.1) | 1756 (91.9) |
| 33–36 weeks—not ventilated | 50 221 | 70 (0.1) | 44 (0.1) | (0)† | 111 (0.2) | 50 110 (99.8) |
| ≥37 weeks— assisted ventilation | 3428 | 184 (5.4) | 102 (3.0) | (0)† | 250 (7.3) | 3178 (92.7) |
| ≥37 weeks—not ventilated | 908 270 | 63 (0.0) | 89 (0.0) | 13 (0.0) | 148 (0.0) | 908 122 (100.0) |
*Neonates can only appear in one cell; neonates with two or more conditions were assigned to the first diagnosis appearing in the above list.
†Numbers ≤5 are not shown and corresponding percentages have been rounded.